Literature DB >> 21158371

Intravitreal bevacizumab following laser therapy for severe retinopathy of prematurity.

Nazmiye Erol1, Hüseyin Gürsoy, Afsun Sahin, Hikmet Basmak.   

Abstract

Trial of intravitreal bevacizumab injection in 7 eyes of 4 infants with continued retinopathy of prematurity progression despite previous laser therapy was reported. Six of the eyes benefited from the therapy. Intravitreal bevacizumab injection may be an alternative therapy in progressive stage 3 retinopathy of prematurity despite laser photocoagulation. Copyright 2010, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21158371     DOI: 10.3928/01913913-20100818-09

Source DB:  PubMed          Journal:  J Pediatr Ophthalmol Strabismus        ISSN: 0191-3913            Impact factor:   1.402


  2 in total

1.  Ranibizumab after laser photocoagulation failure in retinopathy of prematurity (ROP) treatment.

Authors:  Anna Gotz-Więckowska; Anna Chmielarz-Czarnocińska; Marta Pawlak; Janusz Gadzinowski; Jan Mazela
Journal:  Sci Rep       Date:  2017-09-19       Impact factor: 4.379

2.  Bilateral Coats' Disease Combined with Retinopathy of Prematurity.

Authors:  Huseyin Gursoy; Nazmiye Erol; Mustafa Deger Bilgec; Hikmet Basmak; Ozden Kutlay; Huseyin Aslan
Journal:  Case Rep Ophthalmol Med       Date:  2015-08-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.